Neuphoria Therapeutics Inc. (NASDAQ:NEUP) People

Neuphoria Therapeutics Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Spyros Papapetropoulos
Other companies: Lipocine Inc. (Director · Since at least Apr 11, 2022); Vigil Neuroscience Inc (Chief Medical Officer · Jan 6, 2022 – Nov 18, 2022 · Past); Adamas Pharmaceuticals Inc (Director · Nov 22, 2020 – Nov 24, 2021 · Past)
President and CEO, Director · Since at least Jul 1, 2024
Timothy M Cunningham
Other companies: Rein Therapeutics, Inc. (See Remarks · May 16, 2024 – May 16, 2024 · Past); Alaunos Therapeutics, Inc. (interim CFO · Feb 17, 2021 – Feb 17, 2021 · Past); Organogenesis Holdings Inc. (Chief Financial Officer · Dec 10, 2018 – Apr 22, 2020 · Past)
Chief Financial Officer · Jul 1, 2024 – Jul 1, 2024 · Past
Aaron N. D. Weaver
Other companies: Interactive Strength Inc. (Non-Employee Director · Since at least Apr 27, 2023)
Director · Jul 1, 2024 – Jul 1, 2024 · Past
Tim Cunningham
Other companies: Rein Therapeutics, Inc. (Interim Chief Financial Officer · Since at least Nov 4, 2026)
Fractional CFO · Since at least Nov 4, 2026
Alan FisherNon-Executive Chairman · Since at least Jul 1, 2024
David WilsonNon-Executive Director · Since at least Jul 1, 2024
Jane RyanNon-Executive Director · Since at least Jul 1, 2024
Miles DaviesNon-Executive Director · Since at least Dec 8, 2025
Peter Miles Winston DaviesDirector · Since at least Jul 1, 2024
Spyridon PapapetropoulosIR & PR · Since at least Dec 8, 2025